FITC標(biāo)記的14-3-3σ抗體是我司為您提供的高品質(zhì)抗體，公司生產(chǎn)的每一個抗體都經(jīng)過嚴(yán)格檢測和穩(wěn)定性測試，保證了結(jié)果的準(zhǔn)確性、敏感性、特異性。公司產(chǎn)品質(zhì)量有保證，*且我司擁有完善的市場營銷體系、現(xiàn)代化管理體系和專業(yè)化物流配送系統(tǒng)，zui大程度滿足國內(nèi)外生命科研人員的產(chǎn)品需求，公司現(xiàn)經(jīng)營抗體、ELISA試劑盒、標(biāo)準(zhǔn)品、染色液、染色試劑盒、培養(yǎng)基等多種科研產(chǎn)品，歡迎前來選購！
英文名稱 Anti-14-3-3 sigma/FITC
中文名稱 FITC標(biāo)記的14-3-3σ抗體
別 名 14 3 3 protein sigma; 14-3-3 protein sigma; 1433S_HUMAN; Epithelial cell marker protein 1; Er; HME 1; HME1; MGC143283; Mkrn3; Mme1; OTTHUMP00000004242; RP23 137L22.11; SFN; SFN protein; Stratifin; YWHAS.    
說 明 書 100ug  
研究領(lǐng)域 細(xì)胞生物  染色質(zhì)和核信號  神經(jīng)生物學(xué)  信號轉(zhuǎn)導(dǎo)  干細(xì)胞  轉(zhuǎn)錄調(diào)節(jié)因子  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Horse, Rabbit, Sheep, 
產(chǎn)品應(yīng)用 ICC=1:50-200 IF=1:50-200 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 28kDa
性 狀 Lyophilized or Liquid
濃 度 2mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human 14-3-3 sigma
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
FITC標(biāo)記的14-3-3σ抗體保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
FITC標(biāo)記的14-3-3σ抗體產(chǎn)品介紹 background:
14-3-3 proteins regulate many cellular processes relevant to cancer biology, notably apoptosis, mitogenic signaling and cell-cycle checkpoints. Seven isoforms, denoted 14-3-3 b, g, e, z, h, q and s, comprise this family of signaling intermediates. 14-3-3 s, also known as SFN, stratifin, HME1 or YWHAS, is a secreted adaptor protein that is involved in regulating both general and specific signaling pathways. Expressed predominay in stratified squamous keratinising epithelium, 14-3-3 s is able to bind and modify the activity of a large number of proteins, such as KRT17 (Keratin 17), through recognition of a phosphothreonine or phosphoserine motif. When bound to Keratin 17, for example, 14-3-3 s acts to stimulate the Akt/mTOR signaling pathway by upregulating protein synthesis and cell growth. 14-3-3 s also functions to positively mediate IGF-I-induced cell cycle progression and can bind to a variety of translation initiation factors, thus controlling mitotic translation. In response to tumor growth, 14-3-3 s positively regulates the tumor suppressor p53 and increases the rate of p53-regulated inhibition of G2/M cell cycle progression. Multiple isoforms of 14-3-3 s exist due to alternative splicing events.

Function:
Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. When bound to KRT17, regulates protein synthesis and epithelial cell growth by stimulating Akt/mTOR pathway.
p53-regulated inhibitor of G2/M progression.

Subunit:
Homodimer. Interacts with KRT17 and SA1 (By similarity). Found in a complex with XPO7, EIF4A1, ARHGAP1, VPS26A, VPS29, VPS35 and SFN. Interacts with GAB2. Interacts with SRPK2. Interacts with COPS6. Interacts with RFWD2; this interaction leads to proteasomal degradation.

Subcellular Location:
Cytoplasm. Nucleus. Secreted. May be secreted by a non-classical secretory pathway.

Tissue Specificity:
Present mainly in tissues enriched in stratified squamous keratinizing epithelium.

Similarity:
Belongs to the 14-3-3 family.

Database links:
UniProtKB/Swiss-Prot: P31947.1

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.